Notice: This company has been marked as potentially delisted and may not be actively trading. NASDAQ:IMI Intermolecular (IMI) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock Analysis About Intermolecular Stock (NASDAQ:IMI) 30 days 90 days 365 days Advanced Chart Get Intermolecular alerts:Sign Up Key Stats Today's Range$1.20▼$1.2050-Day Range$1.20▼$1.2052-Week Range$0.88▼$1.25VolumeN/AAverage Volume57,852 shsMarket Capitalization$59.71 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewIntermolecular, Inc. engages in the development of advanced materials using high productivity combinatorial (HPC) technology platform for the semiconductors, consumer electronics, automotive, and aerospace industries worldwide. The company's HPC platform includes Tempus processing tools, automated characterization methods, and informatics analysis software for research and development using combinatorial process systems in concert with established chemical vapor deposition, physical vapor deposition, and atomic layer deposition methods. It serves various markets, including semiconductor, glass, advanced alloys, light-emitting diodes, flat-panel displays, and others. The company was formerly known as The BEP Group, Inc. and changed its name to Intermolecular, Inc. in November 2004. Intermolecular, Inc. was founded in 2004 and is headquartered in San Jose, California.Read More… Receive IMI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Intermolecular and its competitors with MarketBeat's FREE daily newsletter. Email Address IMI Stock News HeadlinesInfinity Mining Ltd IMIMay 24, 2024 | morningstar.comIntegrated Micro-Electronics Inc IMIMay 1, 2024 | morningstar.comA deadly mistake in my prediction…I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. February 23, 2025 | Porter & Company (Ad)MSCI EM IMI (MIEF000I0PUS)May 1, 2024 | investing.comAmundi Msci Uk Imi Sri Pab Share Price (C1U.PA)November 25, 2023 | lse.co.ukIMI plc IMINovember 25, 2023 | morningstar.comMorocco earthquake: Watch aftershocks send rescue teams runningSeptember 27, 2023 | bbc.co.ukMSCI ACWI IMI (MIWD000I0PUS)September 24, 2023 | investing.comSee More Headlines IMI Stock Analysis - Frequently Asked Questions How were Intermolecular's earnings last quarter? Intermolecular Inc (NASDAQ:IMI) announced its earnings results on Thursday, August, 8th. The semiconductor company reported ($0.11) earnings per share for the quarter, missing the consensus estimate of ($0.03) by $0.08. The semiconductor company had revenue of $4.62 million for the quarter. Intermolecular had a negative trailing twelve-month return on equity of 33.13% and a negative net margin of 42.74%. What other stocks do shareholders of Intermolecular own? Based on aggregate information from My MarketBeat watchlists, some other companies that Intermolecular investors own include A.H. Belo (AHC), Aerojet Rocketdyne (AJRD), Antares Pharma (ATRS), Genetic Technologies (GENE), CarMax (KMX), Liquidity Services (LQDT) and Orion Energy Systems (OESX). Company Calendar Last Earnings8/08/2019Today2/23/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorComputer and Technology Industry Semiconductors & Related Devices Sub-IndustrySemiconductors Current SymbolNASDAQ:IMI CUSIP45882D10 CIK1311241 Webwww.intermolecular.com Phone408-582-5700FaxN/AEmployees88Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-3,410,000.00 Net Margins-42.74% Pretax MarginN/A Return on Equity-33.13% Return on Assets-23.82% Debt Debt-to-Equity Ratio0.43 Current Ratio4.74 Quick Ratio4.74 Sales & Book Value Annual Sales$33.66 million Price / Sales1.77 Cash Flow$0.03 per share Price / Cash Flow45.51 Book Value$0.69 per share Price / Book1.74Miscellaneous Outstanding Shares49,760,000Free FloatN/AMarket Cap$59.71 million OptionableNot Optionable Beta0.93 10 "Recession Proof" Stocks That Will Thrive in Any MarketWhich stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.Get This Free Report This page (NASDAQ:IMI) was last updated on 2/23/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredElon “obliterates” Bill Gates?All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors ...Altimetry | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredNvidia > DeepSeekEveryone's getting it all wrong … Sure, DeepSeek's reveal caused AI stocks to tumble … But, in the long ...Weiss Ratings | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Intermolecular Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Intermolecular With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.